Voyager Therapeutics, Inc.
VYGR · Biological Products, (No Diagnostic Substances) · 60.4M shares · +6%/yr ↑ shares · EDGAR filings ↗
Reference price $3.87 · est. market cap ~$234M — last insider sale, 2026-04-02 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D44Clinical/early-stage biotech — gene-therapy clinical, heavy burn ($135M), funded.
Strengths
- Liquidity — current ratio 7.6 (69th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Net lossNet loss (net margin -296.5%)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Cash burnNegative free cash flow (-135.1M)
- Exec changeRecent 8-K item 5.02 8-K ↗
- Revenue declineRevenue -83.1% YoY
- Notable holderHeld by 5 notable fund(s): STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC +2 more (as of 2026-03-31)
- Insider sellingInsider selling — 11 open-market sale(s) by 4 insider(s) (cluster of 4 insiders, ~$297,957, last 6mo) Form 4 ↗
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Operating margin
-326.6%
Net margin
-296.5%
Return on equity
-61.1%
Return on assets
-47.5%
Revenue growth (QoQ)
-83.1%
Current ratio
7.6×
Free cash flow
-$135M
Tangible book value
$196M
Cash & investments
$207M
Cash runway
6q
Stock comp / revenue
36.6%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-02 | Sandrock Alfred | Sell | 12K | $3.87 |
| 2026-04-01 | Shiferman Gregory L. | Grant | 50K | — |
| 2026-02-24 | Swartz Robin | Sell | 6.5K | $3.77 |
| 2026-02-24 | Sandrock Alfred | Sell | 14K | $3.79 |
| 2026-02-24 | Jorgensen Nathan D. | Sell | 4.7K | $3.77 |
| 2026-02-24 | Carter Todd Alfred | Sell | 4.2K | $3.76 |
| 2026-02-18 | Swartz Robin | Sell | 3.9K | $3.44 |
| 2026-02-18 | Carter Todd Alfred | Sell | 3.3K | $3.44 |
| 2026-02-18 | Sandrock Alfred | Sell | 12K | $3.41 |
| 2026-02-10 | Swartz Robin | Sell | 4.6K | $3.85 |
| 2026-02-10 | Sandrock Alfred | Sell | 12K | $3.78 |
| 2026-02-10 | Carter Todd Alfred | Sell | 3.5K | $3.85 |
| 2026-02-06 | Ferguson Toby | Grant | 45K | — |
| 2026-02-06 | Carter Todd Alfred | Grant | 33K | — |
| 2026-02-06 | Swartz Robin | Grant | 45K | — |
| 2026-02-06 | Sandrock Alfred | Grant | 86K | — |
| 2026-02-06 | Jorgensen Nathan D. | Grant | 32K | — |
| 2025-10-03 | Jorgensen Nathan D. | Sell | 7.7K | $4.78 |
| 2025-08-18 | Ferguson Toby | Sell | 19K | $3.73 |
| 2025-04-02 | Ferguson Toby | Sell | 10K | $3.43 |
| 2025-04-02 | Sandrock Alfred | Sell | 11K | $3.43 |
| 2025-02-21 | Fahey Sandell Jacquelyn | Grant | 42K | — |
| 2025-02-21 | Carter Todd Alfred | Grant | 46K | — |
| 2025-02-21 | Sandrock Alfred | Grant | 145K | — |
| 2025-02-21 | Swartz Robin | Grant | 71K | — |
| 2025-02-21 | Ferguson Toby | Grant | 63K | — |
| 2025-02-21 | Jorgensen Nathan D. | Grant | 52K | — |
| 2025-02-20 | Swartz Robin | Sell | 3.9K | $4.25 |
| 2025-02-20 | Sandrock Alfred | Sell | 12K | $4.24 |
| 2025-02-20 | Carter Todd Alfred | Sell | 3.3K | $4.26 |
| 2025-02-11 | Sandrock Alfred | Sell | 17K | $4.45 |
| 2025-02-11 | Fahey Sandell Jacquelyn | Sell | 4.4K | $4.45 |
| 2025-02-11 | Carter Todd Alfred | Sell | 5.4K | $4.45 |
| 2025-02-11 | Swartz Robin | Sell | 7.0K | $4.45 |
| 2025-01-14 | Carter Todd Alfred | Sell | 1.2K | $5.13 |
| 2025-01-14 | Swartz Robin | Sell | 3.1K | $5.09 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-10 | 2026-06-09 | 0001104659-26-072324 ↗ |
| 8-K | 2026-06-01 | 2026-06-01 | 0001104659-26-068591 ↗ |
| 8-K | 2026-05-07 | 2026-05-07 | 0001104659-26-057115 ↗ |
| 10-Q | 2026-05-07 | 2026-03-31 | 0001104659-26-057097 ↗ |
| 8-K | 2026-04-21 | 2026-04-15 | 0001104659-26-045997 ↗ |
| 8-K | 2026-03-09 | 2026-03-09 | 0001104659-26-025201 ↗ |
| 10-K | 2026-03-09 | 2025-12-31 | 0001104659-26-025197 ↗ |
| 8-K | 2026-02-12 | 2026-02-09 | 0001104659-26-013897 ↗ |
| 8-K | 2026-01-08 | 2026-01-08 | 0001104659-26-001955 ↗ |
| 8-K | 2025-11-10 | 2025-11-10 | 0001104659-25-108841 ↗ |
| 10-Q | 2025-11-10 | 2025-09-30 | 0001104659-25-108846 ↗ |
| 8-K | 2025-09-02 | 2025-09-02 | 0001104659-25-085977 ↗ |